Jodi Zilinski is a Cardiology physician affiliated with Aurora Health Care. OpenAlex indexes 35 publications with 233 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202524 payments$20,550openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year202541 payments$14,145openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year202551 payments$13,139openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
67.6%Beta blocker30%Metoprolol Succinate69%Carvedilol8%Metoprolol Tartrate7%Nadolol4%Atenolol3%Sotalol3%Propranolol Hcl Er2%Bisoprolol Fumarate1%Propranolol Hcl1%Pindolol1%Part D<11 patientsAntiarrhythmic25.9%Flecainide Acetate35%Amiodarone Hcl34%Dofetilide25%Mexiletine Hcl3%Quinidine Gluconate2%Multaq1%Part D<11 patients+ 8 more classes in this area
Blood & clotting
30.2%Factor Xa inhibitor26.4%Eliquis83%Xarelto17%Part D≥274 patientsVitamin K antagonist2%Warfarin Sodium100%Part D≥31 patients+ 3 more classes in this area
Anti-infectives
0.8%Tetracycline-class Drug0.8%Doxycycline Hyclate100%Part D≥41 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Concurrent Micra Leadless Pacemaker Implantation and AVN Ablation: Computer Modeling of Novel Risk Mitigation Strategy
Pacing and Clinical Electrophysiology
2025 - Comparative Efficacy and Safety of Cryoballoon vs Laser Balloon Ablation for Pulmonary Vein Isolation in Patients With Paroxysmal Atrial Fibrillation
Journal of patient-centered research and reviews
2025 - Suture closure AFtEr large bore vein access (SAFE‐VEIN): A randomized, prospective study of the efficacy and safety of venous closure device
Catheterization and Cardiovascular Interventions
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Suhail Allaqaband, MD
Aurora Health Care
Dajun Wang, MD
Aurora Health Care
Arshad Jahangir, MD
Aurora Health Care
Rubina Qamar, MD
Aurora Health Care
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”